0
Article |

Nifedipine in Hypertensive Emergencies of Children FREE

Uǧur Dilmen, MD; M. Kazim Çaǧlar, MD; D. Ali Şenses, MD; Erol Kinik, MD
[+] Author Affiliations

Reprint requests to Hacettepe Children's Hospital, Ankara, Turkey (Dr Dilmen).


Am J Dis Child. 1983;137(12):1162-1165. doi:10.1001/archpedi.1983.02140380022007.
Text Size: A A A
Published online

• We studied the acute antihypertensive effect of sublingually administered nifedipine in 21 patients with different clinical diagnoses. Nifedipine lowered systolic and diastolic BP from 181 ± 18 and 136 ± 21 mm Hg to 132 ± 15 and 98 ± 17 mm Hg, respectively, after 30 minutes, and produced a slight increase in heart rate. This is the first known study of administration of nifedipine for acute hypertension in children.

(Am J Dis Child 1983;137:1162-1165)

REFERENCES

Braunwald E:  Mechanism of action of calcium-channel blocking agents . N Engl J Med 1982;;307:1618-1627.
Aoki K, Kondo S, Mochizuki A, et al:  Antihypertensive effect of cardiovascular Ca++ antagonist in hypertensive patients in the absence and presence of beta-adrenergic blockade . Am Heart J 1978;;96:218-226.
Lederballe Pederson O, Mikkelsen E:  Acute and chronic effects of nifedipine in arterial hypertension . Eur J Clin Pharmacol 1978;;14:375-381.
Kambara H, Fujimoto K, Wakabayashi A, et al:  Primary pulmonary hypertension: Beneficial therapy with diltiazem . Am Heart J 1981;;101: 230-231.
Stone PH, Muller JE:  Nifedipine therapy for recurrent ischemic pain following myocardial infarction . Clin Cardiol 1982;;5:223-230.
Deanfield J, Wright C, Fox K:  Treatment of angina pectoris with nifedipine: Importance of dose titration . Br Med J 1983;;286:1467-1471.
Matsumoto S, Ito T, Sada T, et al:  Hemodynamic effects of nifedipine in congestive heart failure . Am J Cardiol 1980;;46:476-480.
Klugmann S, Salvi A, Camerini F:  Haemodynamic effects of nifedipine in heart failure . Br Heart J 1980;;43:440-446.
Lorell BH, Paulus WJ, Grossman W, et al:  Modification of abnormal left ventricular diastolic properties by nifedipine in patients with hypertrophic cardiomyopathy . Circulation 1982;; 65:499-507.
Rodeheffer RJ, Rommer JA, Wigley F, et al:  Controlled double-blind trial of nifedipine in the treatment of Raynaud's phenomenon . N Engl J Med 1983;;308:880-883.
Bertel O, Conen D, Radu EW, et al:  Nifedipine in hypertensive emergencies . Br Med J 1983;;286:19-21.
Guazzi M, Olivari MT, Polese A, et al:  Nifedipine a new antihypertensive with rapid action . Clin Pharmacol Ther 1977;;22:528-532.
Beer H, Callegas I, Cohen A, et al:  Efficacy of sublingual nifedipine in the acute treatment of systemic hypertension . Chest 1981;;79: 571-574.
Husted SE, Kreammer Nielsen H, Christensen CK, et al:  Long term therapy of arterial hypertension with nifedipine given alone or in combination with a beta-adrenoreceptor blocking agent . Eur J Clin Pharmacol 1982;;22:101-103.
Ganong WF: Review of Medical Physiology , Los Altos, Calif, Lange Medical Publications, 1981;, pp 43-59.
Kohlhardt M, Bauer B, Krause H, et al:  New selective inhibitors of the transmembrane Ca conductivity in mammalian myocardial fibres: Studies with the voltage clamp technique . Experientia 1972;;28:288-289.
Braunwald E:  Calcium channel blockers: Pharmacologic considerations . Am Heart J 1982;; 104:665-671.
Rowland E, Evans T, Krikler D:  Effect of nifedipine on atrioventricular conduction as compared with verapamil: Intracardiac electrophysiological study . Br Heart J 1979;;42:124-127.
Horster FA:  Pharmacokinetics of nifedipine-14C in man , in Hashimoto K, Kimura E, Kobayashi T (eds): First International Nifedipine (Adalat) Symposium . Tokyo, University of Tokyo Press, 1975;, pp 67-70.
Braasch W, Ebner F:  Long-term treatment with nifedipine , in Hashimoto K, Kimura E, Kobayashi T, eds: First International Nifedipine (Adalat) Symposium . Tokyo, University of Tokyo Press, 1975;, pp 200-204.
Hayase S, Hirakawa S, Hosokawa S, et al:  Therapeutic efficacy: Clinical and basic hemodynamic studies on nifedipine , in Hashimoto K, Kimura E, Kobayashi T (eds): First International Nifedipine (Adalat) Symposium . Tokyo, University of Tokyo Press, 1975;, pp 77-83.
Bertel O, Buhler FR, Kiowski W, et al:  Decreased beta-adrenoreceptor responsiveness as related to age, blood pressure and plasma catecholamines in patients with essential hypertension . Hypertension 1980;;2:130-138.

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Braunwald E:  Mechanism of action of calcium-channel blocking agents . N Engl J Med 1982;;307:1618-1627.
Aoki K, Kondo S, Mochizuki A, et al:  Antihypertensive effect of cardiovascular Ca++ antagonist in hypertensive patients in the absence and presence of beta-adrenergic blockade . Am Heart J 1978;;96:218-226.
Lederballe Pederson O, Mikkelsen E:  Acute and chronic effects of nifedipine in arterial hypertension . Eur J Clin Pharmacol 1978;;14:375-381.
Kambara H, Fujimoto K, Wakabayashi A, et al:  Primary pulmonary hypertension: Beneficial therapy with diltiazem . Am Heart J 1981;;101: 230-231.
Stone PH, Muller JE:  Nifedipine therapy for recurrent ischemic pain following myocardial infarction . Clin Cardiol 1982;;5:223-230.
Deanfield J, Wright C, Fox K:  Treatment of angina pectoris with nifedipine: Importance of dose titration . Br Med J 1983;;286:1467-1471.
Matsumoto S, Ito T, Sada T, et al:  Hemodynamic effects of nifedipine in congestive heart failure . Am J Cardiol 1980;;46:476-480.
Klugmann S, Salvi A, Camerini F:  Haemodynamic effects of nifedipine in heart failure . Br Heart J 1980;;43:440-446.
Lorell BH, Paulus WJ, Grossman W, et al:  Modification of abnormal left ventricular diastolic properties by nifedipine in patients with hypertrophic cardiomyopathy . Circulation 1982;; 65:499-507.
Rodeheffer RJ, Rommer JA, Wigley F, et al:  Controlled double-blind trial of nifedipine in the treatment of Raynaud's phenomenon . N Engl J Med 1983;;308:880-883.
Bertel O, Conen D, Radu EW, et al:  Nifedipine in hypertensive emergencies . Br Med J 1983;;286:19-21.
Guazzi M, Olivari MT, Polese A, et al:  Nifedipine a new antihypertensive with rapid action . Clin Pharmacol Ther 1977;;22:528-532.
Beer H, Callegas I, Cohen A, et al:  Efficacy of sublingual nifedipine in the acute treatment of systemic hypertension . Chest 1981;;79: 571-574.
Husted SE, Kreammer Nielsen H, Christensen CK, et al:  Long term therapy of arterial hypertension with nifedipine given alone or in combination with a beta-adrenoreceptor blocking agent . Eur J Clin Pharmacol 1982;;22:101-103.
Ganong WF: Review of Medical Physiology , Los Altos, Calif, Lange Medical Publications, 1981;, pp 43-59.
Kohlhardt M, Bauer B, Krause H, et al:  New selective inhibitors of the transmembrane Ca conductivity in mammalian myocardial fibres: Studies with the voltage clamp technique . Experientia 1972;;28:288-289.
Braunwald E:  Calcium channel blockers: Pharmacologic considerations . Am Heart J 1982;; 104:665-671.
Rowland E, Evans T, Krikler D:  Effect of nifedipine on atrioventricular conduction as compared with verapamil: Intracardiac electrophysiological study . Br Heart J 1979;;42:124-127.
Horster FA:  Pharmacokinetics of nifedipine-14C in man , in Hashimoto K, Kimura E, Kobayashi T (eds): First International Nifedipine (Adalat) Symposium . Tokyo, University of Tokyo Press, 1975;, pp 67-70.
Braasch W, Ebner F:  Long-term treatment with nifedipine , in Hashimoto K, Kimura E, Kobayashi T, eds: First International Nifedipine (Adalat) Symposium . Tokyo, University of Tokyo Press, 1975;, pp 200-204.
Hayase S, Hirakawa S, Hosokawa S, et al:  Therapeutic efficacy: Clinical and basic hemodynamic studies on nifedipine , in Hashimoto K, Kimura E, Kobayashi T (eds): First International Nifedipine (Adalat) Symposium . Tokyo, University of Tokyo Press, 1975;, pp 77-83.
Bertel O, Buhler FR, Kiowski W, et al:  Decreased beta-adrenoreceptor responsiveness as related to age, blood pressure and plasma catecholamines in patients with essential hypertension . Hypertension 1980;;2:130-138.

Correspondence

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.